Framingham Massachusetts based Solace Therapeutics is raising $17,550,000.00 in New Equity Investment.
Framingham, MA – According to filings with the U.S. Securities and Exchange Commission, Solace Therapeutics is raising $17,550,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, William Gruber…